Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Cross

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|October 1, 1996
Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferonJ R Seale, S Varma, D M Swirsky, et al.
Molecular Biology & Medicine|February 1, 1991
Regulation and expression of type V (tartrate-resistant) acid phosphatase in human mononuclear phagocytesM A Bevilacqua, D K Lord, N C Cross, et al.
Bone Marrow Transplantation|March 1, 1996
Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CMLH Sill, S A Rule, D J Joske, et al.
Genes, Chromosomes & Cancer|April 1, 1995
Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13H Kempski, D MacDonald, A J Michalski, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Leukemia|July 1, 1997
Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemiaM Carapeti, A Soede-Bobok, A Hochhaus, et al.
British Journal of Haematology|April 1, 1997
Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. German chronic myeloid leukaemia (CML) Study GroupA Reiter, H Skladny, A Hochhaus, et al.
Leukemia|August 1, 1993
Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and reviewM N Potter, N C Cross, J J van Dongen, et al.
Bone Marrow Transplantation|October 1, 1994
Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemiaF van Rhee, F Lin, N C Cross, et al.
Blood|January 28, 1999
Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12)A Chase, A Reiter, L Burci, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|October 1, 1996
Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferonJ R Seale, S Varma, D M Swirsky, et al.
Molecular Biology & Medicine|February 1, 1991
Regulation and expression of type V (tartrate-resistant) acid phosphatase in human mononuclear phagocytesM A Bevilacqua, D K Lord, N C Cross, et al.
Bone Marrow Transplantation|March 1, 1996
Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CMLH Sill, S A Rule, D J Joske, et al.
Genes, Chromosomes & Cancer|April 1, 1995
Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13H Kempski, D MacDonald, A J Michalski, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Leukemia|July 1, 1997
Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemiaM Carapeti, A Soede-Bobok, A Hochhaus, et al.
British Journal of Haematology|April 1, 1997
Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. German chronic myeloid leukaemia (CML) Study GroupA Reiter, H Skladny, A Hochhaus, et al.
Leukemia|August 1, 1993
Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and reviewM N Potter, N C Cross, J J van Dongen, et al.
Bone Marrow Transplantation|October 1, 1994
Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemiaF van Rhee, F Lin, N C Cross, et al.
Blood|January 28, 1999
Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12)A Chase, A Reiter, L Burci, et al.
Pageof 12